Mathematical Model for Bone Mineralization
Overview
Authors
Affiliations
Defective bone mineralization has serious clinical manifestations, including deformities and fractures, but the regulation of this extracellular process is not fully understood. We have developed a mathematical model consisting of ordinary differential equations that describe collagen maturation, production and degradation of inhibitors, and mineral nucleation and growth. We examined the roles of individual processes in generating normal and abnormal mineralization patterns characterized using two outcome measures: mineralization lag time and degree of mineralization. Model parameters describing the formation of hydroxyapatite mineral on the nucleating centers most potently affected the degree of mineralization, while the parameters describing inhibitor homeostasis most effectively changed the mineralization lag time. Of interest, a parameter describing the rate of matrix maturation emerged as being capable of counter-intuitively increasing both the mineralization lag time and the degree of mineralization. We validated the accuracy of model predictions using known diseases of bone mineralization such as osteogenesis imperfecta and X-linked hypophosphatemia. The model successfully describes the highly nonlinear mineralization dynamics, which includes an initial lag phase when osteoid is present but no mineralization is evident, then fast primary mineralization, followed by secondary mineralization characterized by a continuous slow increase in bone mineral content. The developed model can potentially predict the function for a mutated protein based on the histology of pathologic bone samples from mineralization disorders of unknown etiology.
Geng Z, Xu F, Liu Y, Qiao A, Du T J Funct Biomater. 2024; 15(12.
PMID: 39728156 PMC: 11728303. DOI: 10.3390/jfb15120356.
Mathematical model capturing physicochemical and biological regulation of bone mineralization.
Poorhemati H, Komarova S Sci Rep. 2024; 14(1):29831.
PMID: 39616262 PMC: 11608267. DOI: 10.1038/s41598-024-81472-1.
Targeting strategies for bone diseases: signaling pathways and clinical studies.
Xu H, Wang W, Liu X, Huang W, Zhu C, Xu Y Signal Transduct Target Ther. 2023; 8(1):202.
PMID: 37198232 PMC: 10192458. DOI: 10.1038/s41392-023-01467-8.
Monteiro-Lobato G, Russo P, Winck F, Catalani L Biomed Res Int. 2022; 2022:6884370.
PMID: 36267842 PMC: 9578822. DOI: 10.1155/2022/6884370.
Molecular Quantity Variations in Human-Mandibular-Bone Osteoid.
Palander A, Fauch L, Turunen M, Dekker H, Schulten E, Koistinen A Calcif Tissue Int. 2022; 111(6):547-558.
PMID: 35978052 PMC: 9613710. DOI: 10.1007/s00223-022-01017-4.